KAT6A, a novel regulator of β-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1
Wenxue Liu, Zhiyan Zhan, Meiying Zhang, Bowen Sun, Qiqi Shi, Fei Luo, Mingda Zhang, Weiwei Zhang, Yanli Hou, Xiuying Xiao, Yanxin Li, Haizhong Feng
Abstract
Our findings suggest that the KAT6A/COP1/β-catenin signaling axis plays a critical role in ovarian cancer progression and that targeting the KAT6A/COP1/β-catenin signaling axis could be a novel strategy for treating ovarian cancer.
Topics & Concepts
Ovarian cancerCancer researchCancerMalignancyLeukemiaRegulatorHistone acetyltransferaseBiologyMedicineInternal medicineHistoneGeneticsGeneGenomics and Chromatin DynamicsEpigenetics and DNA MethylationRNA modifications and cancer